• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值对终末期肾病患者预后的预测价值

The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients.

作者信息

Mureșan Adrian Vasile, Russu Eliza, Arbănași Emil Marian, Kaller Réka, Hosu Ioan, Arbănași Eliza Mihaela, Voidăzan Septimiu Toader

机构信息

Clinic of Vascular Surgery, Mureș County Emergency Hospital, 540136 Târgu Mureș, Romania.

Department of Surgery, George Emil Palade University of Medicine, Pharmacy, Science, and Technology of Targu Mures, 540139 Târgu Mureș, Romania.

出版信息

Biomedicines. 2022 May 29;10(6):1272. doi: 10.3390/biomedicines10061272.

DOI:10.3390/biomedicines10061272
PMID:35740294
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9220159/
Abstract

Background: Chronic kidney disease (CKD) is a global public health problem with a high mortality rate and a rapid progression to end-stage kidney disease (ESKD). Recently, the role of inflammation and the correlation between inflammatory markers and CKD progression have been studied. This study aimed to analyze the predictive value of the neutrophil−lymphocyte ratio (NLR), monocyte-to-lymphocyte ratio (MLR), and platelet-to-lymphocyte ratio (PLR) in assessing the outcome of ESKD patients. Methods: A retrospective study which included all patients admitted in the Department of Nephrology of the County Emergency Clinical Hospital, Târgu-Mureș, Romania, between January 2016 and December 2019, diagnosed with ESKD. Results: Mortality at 30 days was clearly higher in the case of the patients in the high-NLR groups (40.12% vs. 1.97%; p < 0.0001), high-MLR (32.35% vs. 4.81%; p < 0.0001), and respectively high-PLR (25.54% vs. 7.94%; p < 0.0001). There was also a significant increase in the number of hospital days and the average number of dialysis sessions in patients with high-NLR (p < 0.0001), high-MLR (p < 0.0001), and high-PLR (p < 0.0001). The multivariate analysis showed that a high baseline value for NLR (p < 0.0001), MLR (p < 0.0001), and PLR (p < 0.0001) was an independent predictor of 30-day mortality for all recruited patients. Conclusions: Our findings established that NLR, MLR, and PLR determined at hospital admission had a strong predictive capacity of all-cause 30-day mortality in ESKD patients who required RRT for at least 6 months. Elevated values of the ratios were also associated with longer hospital stays and more dialysis sessions per patient.

摘要

背景

慢性肾脏病(CKD)是一个全球性的公共卫生问题,死亡率高且迅速进展为终末期肾病(ESKD)。最近,炎症的作用以及炎症标志物与CKD进展之间的相关性已得到研究。本研究旨在分析中性粒细胞与淋巴细胞比值(NLR)、单核细胞与淋巴细胞比值(MLR)和血小板与淋巴细胞比值(PLR)在评估ESKD患者预后中的预测价值。方法:一项回顾性研究,纳入2016年1月至2019年12月期间在罗马尼亚特尔古穆列什县急诊临床医院肾病科住院的所有诊断为ESKD的患者。结果:高NLR组患者30天死亡率明显更高(40.12%对1.97%;p<0.0001),高MLR组(32.35%对4.81%;p<0.0001),以及高PLR组(25.54%对7.94%;p<0.0001)。高NLR(p<0.0001)、高MLR(p<0.0001)和高PLR(p<0.0001)患者的住院天数和平均透析次数也显著增加。多因素分析显示,NLR(p<0.0001)、MLR(p<0.0001)和PLR(p<0.0001)的高基线值是所有纳入患者30天死亡率的独立预测因素。结论:我们的研究结果表明,入院时测定的NLR、MLR和PLR对至少需要6个月肾脏替代治疗(RRT)的ESKD患者的30天全因死亡率具有很强的预测能力。这些比值升高还与患者更长的住院时间和更多的透析次数相关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/9220159/e771678a41b4/biomedicines-10-01272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/9220159/fdb4be5597ca/biomedicines-10-01272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/9220159/e771678a41b4/biomedicines-10-01272-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/9220159/fdb4be5597ca/biomedicines-10-01272-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/256b/9220159/e771678a41b4/biomedicines-10-01272-g002.jpg

相似文献

1
The Predictive Value of NLR, MLR, and PLR in the Outcome of End-Stage Kidney Disease Patients.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值对终末期肾病患者预后的预测价值
Biomedicines. 2022 May 29;10(6):1272. doi: 10.3390/biomedicines10061272.
2
Prognostic value of the combination of neutrophil-to-lymphocyte ratio, monocyte-to-lymphocyte ratio and platelet-to-lymphocyte ratio on mortality in patients on maintenance hemodialysis.中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值及血小板与淋巴细胞比值联合对维持性血液透析患者死亡率的预后价值。
BMC Nephrol. 2022 Dec 8;23(1):393. doi: 10.1186/s12882-022-03020-1.
3
Correlation of Hemoglobin Level With New Inflammatory Markers in the Emergency Department: A Retrospective Study Exploring Neutrophil-to-Lymphocyte, Monocyte-to-Lymphocyte, Platelet-to-Lymphocyte, and Mean Platelet Volume-to-Platelet Count Ratios.急诊科血红蛋白水平与新炎症标志物的相关性:一项探索中性粒细胞与淋巴细胞、单核细胞与淋巴细胞、血小板与淋巴细胞以及平均血小板体积与血小板计数比值的回顾性研究。
Cureus. 2024 Mar 2;16(3):e55401. doi: 10.7759/cureus.55401. eCollection 2024 Mar.
4
The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease.中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对股腘动脉疾病患者下肢血管重建术预后及通畅情况的预测作用
J Clin Med. 2022 May 6;11(9):2620. doi: 10.3390/jcm11092620.
5
Can Neutrophil-to-Lymphocyte Ratio, Monocyte-to-Lymphocyte Ratio, and Platelet-to-Lymphocyte Ratio at Day +100 be used as a prognostic marker in Multiple Myeloma patients with autologous transplantation?中性粒细胞与淋巴细胞比值、单核细胞与淋巴细胞比值和血小板与淋巴细胞比值在第 +100 天能否作为自体移植多发性骨髓瘤患者的预后标志物?
Clin Transplant. 2018 Sep;32(9):e13359. doi: 10.1111/ctr.13359. Epub 2018 Aug 26.
6
The Prognostic Value of Platelet-Lymphocyte Ratio, Neutrophil-Lymphocyte Ratio, and Monocyte-Lymphocyte Ratio in Head and Neck Squamous Cell Carcinoma (HNSCC)-A Retrospective Single Center Study and a Literature Review.血小板淋巴细胞比率、中性粒细胞淋巴细胞比率及单核细胞淋巴细胞比率在头颈部鳞状细胞癌(HNSCC)中的预后价值——一项回顾性单中心研究及文献综述
Diagnostics (Basel). 2023 Nov 7;13(22):3396. doi: 10.3390/diagnostics13223396.
7
Are Neutrophil-Lymphocyte, Platelet-Lymphocyte, and Monocyte-Lymphocyte Ratios Prognostic Indicators in Patients With Chronic Obstructive Pulmonary Disease in Intensive Care Units?中性粒细胞与淋巴细胞、血小板与淋巴细胞以及单核细胞与淋巴细胞比值是重症监护病房中慢性阻塞性肺疾病患者的预后指标吗?
Cureus. 2022 Mar 26;14(3):e23499. doi: 10.7759/cureus.23499. eCollection 2022 Mar.
8
Systemic Inflammatory Biomarkers and Chest CT Findings as Predictors of Acute Limb Ischemia Risk, Intensive Care Unit Admission, and Mortality in COVID-19 Patients.全身炎症生物标志物和胸部CT表现作为COVID-19患者急性肢体缺血风险、重症监护病房入院率和死亡率的预测指标
Diagnostics (Basel). 2022 Sep 30;12(10):2379. doi: 10.3390/diagnostics12102379.
9
Decreased monocyte-to-lymphocyte ratio was associated with satisfied outcomes of first-line PD-1 inhibitors plus chemotherapy in stage IIIB-IV non-small cell lung cancer.单核细胞与淋巴细胞比值降低与 IIIB-IV 期非小细胞肺癌一线 PD-1 抑制剂联合化疗的满意结局相关。
Front Immunol. 2023 Jan 26;14:1094378. doi: 10.3389/fimmu.2023.1094378. eCollection 2023.
10
Inflammatory Biomarkers as Prognostic Factors of Acute Deep Vein Thrombosis Following the Total Knee Arthroplasty.炎症生物标志物作为全膝关节置换术后急性深静脉血栓形成的预后因素。
Medicina (Kaunas). 2022 Oct 21;58(10):1502. doi: 10.3390/medicina58101502.

引用本文的文献

1
Neutrophil-to-albumin ratio for predicting mortality in chronic kidney diseases: A cohort study on all-cause and cardiovascular mortality from NHANES 1999 to 2018.中性粒细胞与白蛋白比值预测慢性肾脏病死亡率:一项关于1999年至2018年美国国家健康与营养检查调查全因死亡率和心血管死亡率的队列研究。
Medicine (Baltimore). 2025 Aug 8;104(32):e43666. doi: 10.1097/MD.0000000000043666.
2
Correlation Between Peripheral Blood Immune Cell Distribution and Disease Severity and Prognosis in Multiple Sclerosis Patients.多发性硬化症患者外周血免疫细胞分布与疾病严重程度及预后的相关性
J Inflamm Res. 2025 Jul 28;18:10051-10059. doi: 10.2147/JIR.S519729. eCollection 2025.
3

本文引用的文献

1
The Predictive Role of NLR and PLR in Outcome and Patency of Lower Limb Revascularization in Patients with Femoropopliteal Disease.中性粒细胞与淋巴细胞比值(NLR)和血小板与淋巴细胞比值(PLR)对股腘动脉疾病患者下肢血管重建术预后及通畅情况的预测作用
J Clin Med. 2022 May 6;11(9):2620. doi: 10.3390/jcm11092620.
2
Uncommon Surgical Management by AVF between the Great Saphenous Vein and Anterior Tibial Artery for Old Radiocephalic AVF Failure.大隐静脉与胫前动脉之间自体动静脉内瘘术治疗陈旧性桡动脉-头静脉内瘘失功的罕见外科处理
Life (Basel). 2022 Apr 3;12(4):529. doi: 10.3390/life12040529.
3
The ERA Registry Annual Report 2019: summary and age comparisons.
Relationship between lymphocyte-related parameters and the prognosis of patients with lupus nephritis.
淋巴细胞相关参数与狼疮性肾炎患者预后的关系。
Front Immunol. 2025 Jul 8;16:1613483. doi: 10.3389/fimmu.2025.1613483. eCollection 2025.
4
Single-cell transcriptomics yield insights into the stress-immune interplay and inform disease risk.单细胞转录组学揭示了应激与免疫之间的相互作用,并为疾病风险提供了信息。
bioRxiv. 2025 Jun 12:2025.06.05.658150. doi: 10.1101/2025.06.05.658150.
5
Prognostic implications of systemic immune-inflammation index and systemic inflammation response index in hemodialysis patients.血液透析患者全身免疫炎症指数和全身炎症反应指数的预后意义
BMC Nephrol. 2025 Jul 1;26(1):322. doi: 10.1186/s12882-025-04223-y.
6
The Role of Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio in Predicting Atrial Fibrillation and Its Comorbidities.中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值在预测心房颤动及其合并症中的作用
Life (Basel). 2025 Jun 16;15(6):960. doi: 10.3390/life15060960.
7
Combined prediction value of coronary plaque burden, serum creatinine, MLR and NLR in reinfarction risk after PCI in middle-aged and elderly patients with myocardial infarction.心肌梗死中老年患者PCI术后再梗死风险中冠状动脉斑块负荷、血清肌酐、单核细胞与淋巴细胞比值及中性粒细胞与淋巴细胞比值的联合预测价值
Eur J Med Res. 2025 Jun 24;30(1):522. doi: 10.1186/s40001-025-02804-z.
8
The Association of Blood Cobalt Levels with Cardiovascular and Chronic Kidney Diseases: Mediating Role of Inflammatory Indicators (SII, NLR, PLR, NMLR, and LMR).血钴水平与心血管疾病和慢性肾脏病的关联:炎症指标(全身免疫炎症指数、中性粒细胞与淋巴细胞比值、血小板与淋巴细胞比值、中性粒细胞与单核细胞比值及淋巴细胞与单核细胞比值)的中介作用
Cardiovasc Toxicol. 2025 Jun 18. doi: 10.1007/s12012-025-10018-2.
9
The systemic immune-inflammation index (SII) as a biomarker for depression in a community sample of adolescents.作为青少年社区样本中抑郁症生物标志物的全身免疫炎症指数(SII)。
Compr Psychoneuroendocrinol. 2025 May 16;23:100302. doi: 10.1016/j.cpnec.2025.100302. eCollection 2025 Aug.
10
A prospective cohort study on the association between neutrophil-to-lymphocyte and platelet-to-lymphocyte ratios and gestational diabetes mellitus in Chinese pregnant women.一项关于中国孕妇中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值与妊娠期糖尿病之间关联的前瞻性队列研究。
Front Endocrinol (Lausanne). 2025 Apr 14;16:1477092. doi: 10.3389/fendo.2025.1477092. eCollection 2025.
《2019年ERA注册机构年度报告:总结与年龄比较》
Clin Kidney J. 2021 Dec 15;15(3):452-472. doi: 10.1093/ckj/sfab273. eCollection 2022 Mar.
4
Neutrophil-to-Lymphocyte and Platelet-to-Lymphocyte Ratios in Nondialysis Chronic Kidney Patients.非透析慢性肾病患者的中性粒细胞与淋巴细胞比值及血小板与淋巴细胞比值
Int J Inflam. 2021 Jun 23;2021:6678960. doi: 10.1155/2021/6678960. eCollection 2021.
5
High Neutrophil-to-Lymphocyte Ratio and Platelet-to-Lymphocyte Ratio Are Associated with Poor Survival in Patients with Hemodialysis.高中性粒细胞与淋巴细胞比值和血小板与淋巴细胞比值与血液透析患者的不良生存相关。
Biomed Res Int. 2021 May 19;2021:9958081. doi: 10.1155/2021/9958081. eCollection 2021.
6
Association of platelet-to-lymphocyte ratio with kidney clinicopathologic features and renal outcomes in patients with diabetic kidney disease.血小板与淋巴细胞比值与糖尿病肾病患者肾脏临床病理特征及肾脏结局的关系。
Int Immunopharmacol. 2021 Apr;93:107413. doi: 10.1016/j.intimp.2021.107413. Epub 2021 Jan 29.
7
Neutrophil to Lymphocyte Ratio as a Predictor of Long-Term Outcome in Peritoneal Dialysis Patients: A 5-Year Cohort Study.中性粒细胞与淋巴细胞比值对腹膜透析患者长期预后的预测价值:一项 5 年队列研究。
Blood Purif. 2021;50(6):772-778. doi: 10.1159/000510552. Epub 2021 Jan 28.
8
Neutrophil-to-lymphocyte ratio in relation to the risk of all-cause mortality and cardiovascular events in patients with chronic kidney disease: a systematic review and meta-analysis.中性粒细胞与淋巴细胞比值与慢性肾脏病患者全因死亡率和心血管事件风险的关系:系统评价和荟萃分析。
Ren Fail. 2020 Nov;42(1):1059-1066. doi: 10.1080/0886022X.2020.1832521.
9
Association of neutrophil-to-lymphocyte ratio and risk of cardiovascular or all-cause mortality in chronic kidney disease: a meta-analysis.中性粒细胞与淋巴细胞比值与慢性肾脏病患者心血管疾病或全因死亡风险的关联:一项荟萃分析
Clin Exp Nephrol. 2021 Feb;25(2):157-165. doi: 10.1007/s10157-020-01975-9. Epub 2020 Oct 6.
10
Neutrophil-to-lymphocyte ratio and red blood cell distribution width-to-platelet ratio predict cardiovascular events in hemodialysis patients.中性粒细胞与淋巴细胞比值及红细胞分布宽度与血小板比值可预测血液透析患者的心血管事件。
Exp Ther Med. 2020 Aug;20(2):1105-1114. doi: 10.3892/etm.2020.8756. Epub 2020 May 15.